COLLIER COLLECTIVE, LLC for DRUG POLICY ACTION
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
1. Advocated for increased FY22 funding in the Labor, Health & Human Services, Education, and Related Agencies appropriations bill for HHS/CDC's Infectious Diseases & Opioid Epidemic program to expand access to overdose prevention and other harm reduction services to help prevent skyrocketing overdose deaths nationwide and prevent the transmission of infectious diseases. 2. Advocated for funding to support access to harm reduction programs within the American Rescue Plan Act enacted this Congress. These funds were allocated to HHS/SAMHSA and urged ONDCP & SAMHSA to implement funding expeditiously to support harm reduction programs in need of support as a result of reduced resources during the COVID-19 pandemic.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNY COLLIER | — |
| DANIELLE NEAL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.